Skip to main content
OpenTrials
Completed

NCT Number: NCT02450461

Breath Analysis in Asthma

The purpose of this study is to answer the question whether a disease-specific profile of breath in patients with asthma can be detected by an untargeted metabolomic study using exhaled breath analysis by mass spectrometry.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Zurich, Pulmonary Division

Zurich, 8091, Switzerland

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Confirmed asthma. Diagnosis of asthma is made with episodic chest symptoms and a documented reversibility of at least 12% and/or 200 ml in FEV1 after 200 ug of inhaled salbutamol or airway hyperresponsiveness in the case of normal lung function testing (PC20 methacholine < 4mg/ml) at the time of diagnosis.
  • Age between 18 and 80 years at study entry.
  • Healthy controls: never-smokers, normal spirometry (baseline FEV1 > 85% predicted and FEV1/FVC greater than 0.7).

Exclusion criteria

  • Asthma exacerbation within the last 6 weeks, defined as worsening of asthma symptoms requiring a change in therapy by a physician or a change in regular asthma therapy (including short course of oral corticosteroids)
  • Any lung disease other than asthma.
  • Acute inflammatory disease (e.g. common cold) within the last 4 weeks.
  • Regular intake of oral steroids.
  • Active smoking habits / positive history of smoking.
  • Acute or chronic hepatic disease.
  • Renal failure or renal replacement therapy.
  • Pregnancy.

Treatment and study plan

No intervention

Other

Primary outcomes

  1. The primary outcome will be the asthma specific mass spectrometric profile of VOCs of exhaled breath analysis (markers of asthma in exhaled breath)

    Time frame: 1 day, single measurement, no follow up

Sponsors and collaborators

Lead sponsor

University of Zurich

Other

Collaborators

  • Swiss Federal Institute of Technology

Registry information

Official study title

Exhaled Breath Analysis by Secondary Electrospray Ionization (SESI-MS) in Patients With Asthma

Important dates

Study start
2015
Primary completion
2016
Study completion
2017
First posted
May 21, 2015
Registry last updated
Aug 11, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.